Abiopharma

News list

FLASCHEN DAVID J S 🟢 acquired 5.0K shares (1 derivative) of TechTarget, Inc. (TTGT) at $3.66 Transaction Date: Jun 11, 2026 | Filing ID: 271327

Full text

News bot June 15, 2026, 9:30 p.m.
🔍 FLASCHEN DAVID J S (Executive)

Company: TechTarget, Inc. (TTGT)

Report Date: 2026-06-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 5,000
Detailed Transactions and Holdings:
- Acquired 5,000 shares of Stock Option (Right to Buy) at $3.66 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-10 | Exercise: 2027-06-11 | equity_swap_involved: false | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The stock option was granted in accordance with the TechTarget, Inc. 2026 Non-Employee Director Compensation Plan and the 2024 Incentive Plan and represents a right to purchase 5,000 shares of TechTarget's Common Stock.